Sphere Fluidics
https://www.spherefluidics.com
Sphere Fluidics is a life sciences company, based in Cambridgeshire, UK and New Jersey, USA. Sphere Fluidics offers a novel platform (Cyto-Mine®) that performs single cell analysis.
Cyto-Mine® reduces costs for biopharmaceutical discovery and development. It is being adapted to single cell engineering using synthetic biology or genome editing.
In the media
16th April 2019
Fujifilm Announces The Introduction Of A 10 Week Cell Line Development Timeline With Its Apollo X Advanced Mammalian Expression System
monoclonal antibody expression in 10 weeks (transfection to generation of research cell banks) using Sphere Fluidics Cyto-Mine Technology followed by Cell Metric
16th April 2019
Fujifilm Announces The Introduction Of A 10 Week Cell Line Development Timeline With Its Apollo X Advanced Mammalian Expression System
monoclonal antibody expression in 10 weeks (transfection to generation of research cell banks) using Sphere Fluidics Cyto-Mine Technology followed by Cell Metric
15th April 2019
Fujifilm Accelerates Cell Line Devt. Timelines
Advanced Mammalian Expression System allows for cell line development for monoclonal antibody expression in 10 weeks—transfection to generation of research cell banks—using Sphere Fluidics Cyto-Mine Technology followed by Cell Metric